Mariam E. Morris
2016
In 2016, Mariam E. Morris earned a total compensation of $432.1K as Chief Financial Officer at Avalo Therapeutics.
Compensation breakdown
| Option Awards | $112,231 |
|---|---|
| Salary | $295,200 |
| Other | $24,696 |
| Total | $432,127 |
Morris received $295.2K in salary, accounting for 68% of the total pay in 2016.
Morris also received $112.2K in option awards and $24.7K in other compensation.
Rankings
In 2016, Mariam E. Morris' compensation ranked 11,671st out of 14,075 executives tracked by ExecPay. In other words, Morris earned more than 17.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,671 out of 14,075 | 17th |
Division Manufacturing | 4,555 out of 5,486 | 17th |
Major group Chemicals And Allied Products | 1,629 out of 1,900 | 14th |
Industry group Drugs | 1,318 out of 1,543 | 15th |
Industry Pharmaceutical Preparations | 1,018 out of 1,173 | 13th |
Source: SEC filing on April 5, 2018.
Morris' colleagues
We found three more compensation records of executives who worked with Mariam E. Morris at Avalo Therapeutics in 2016.